Home
  >  
Section 12
  >  
Chapter 11,779

Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET

Mitwally, M.F.M.; Bhakoo, H.S.; Crickard, K.; Sullivan, M.W.; Batt, R.E.; Yehl, J.

Journal of Assisted Reproduction and Genetics 22(2): 57-63

2005

ISSN/ISBN: 1058-0468
PMID: 15844730
DOI: 10.1007/s10815-005-1494-4
Accession: 011778288
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Purpose: Most studies reported estradiol (E-2) levels attained on day of hCG administration when investigating effect of E-2 on IVF outcome. We studied whether a relationship exists between the area under the curve for E-2 levels (AUC-E-2) and E-2 levels on hCG day during IVF-ET.Methods: Retrospectively, we analyzed data for 313 patients who completed one IVF-ET cycle each. Patients were sorted according to AUC-E-2 levels.

PDF emailed within 0-6 h: $19.90




Related References

Mohamed, F.M. Mitwally; Hemlata, S. Bhakoo; Kent Crickard; Michael, W. Sullivan; Ronald, E. Batt; John Yeh 2003: AUC (Area Under The Curve) for E2 (Estradiol) levels do not reflect E2 levels on the day of hCG administration among individual patients undergoing COH (Controlled Ovarian Hyperstimulation) for IVF-ET (In-Vitro Fertilization and Embryo Transfer) Fertility and Sterility 80(Supp-S3): 137-138
Phelps, J.Y.; Levine, A.S.; Hickman, T.N.; Zacur, H.A.; Wallach, E.E.; Hinton, E.L. 1998: Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF Fertility and Sterility 69(6): 1015-1019
Lunenfeld, E.; Potashnik, G.; Yohay, D.; Sharoni, Y.; Levy, J. 1996: The relationship between GH, IGF-I, IGF-II, IGF-BP-3 and 17β-estradiol plasma levels in patients undergoing controlled ovarian hyperstimulation -possible implication on implantation Gynecological Endocrinology 10(Sup 4): 90-91
Wang, J.; Luo, W.; Diao, F.; Mao, Y.; Liu, J. 2014: High serum estradiol levels on the day of hCg administration during controlled ovarian hyperstimulation is associated with the increased risk of ectopic pregnancy in a dose-response manner Fertility and Sterility 102(3): e239-e240
Järvelä, I.Y.; Pelkonen, S.; Uimari, O.; Mäkikallio, K.; Puukka, K.; Ruokonen, A.; Tekay, A.; Martikainen, H. 2014: Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy Human Reproduction 29(11): 2393-2401
Ben-Shlomo, I.; Geslevich, J.; Shalev, E. 2001: Can we abandon routine evaluation of serum estradiol levels during controlled ovarian hyperstimulation for assisted reproduction? Fertility and Sterility 76(2): 300-303
Madrazo, I.; Vélez, M.F.; Hidalgo, J.J.; Ortiz, G.; Suárez, J.J.é; Porchia, L.M.; Gonzalez-Mejia, M.E.; López-Bayghen, E. 2020: Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles Journal of International Medical Research 48(8): 300060520945551
Cheng, J-Chien.; Fang, L.; Li, Y.; Wang, S.; Li, Y.; Yan, Y.; Jia, Q.; Wu, Z.; Wang, Z.; Han, X.; Sun, Y-Pu. 2020: Melatonin stimulates aromatase expression and estradiol production in human granulosa-lutein cells: relevance for high serum estradiol levels in patients with ovarian hyperstimulation syndrome Experimental and Molecular Medicine 52(8): 1341-1350
Amaro, A.; Polerá, D.; Figueiredo, F.W.D.S.; Bianco, B.; Christofolini, D.M.; Barbosa, C.P. 2019: The Impact of Variants in Genes Associated with Estradiol Synthesis on Hormone Levels and Oocyte Retrieval in Patients who Underwent Controlled Ovarian Hyperstimulation Genetic Testing and Molecular Biomarkers 23(2): 145-149
Joo, B.S.; Park, S.H.; An, B.M.; Kim, K.S.; Moon, S.E.; Moon, H.S. 2010: Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner Fertility and Sterility 93(2): 442-446
Pereira, N.; Reichman, D.E.; Goldschlag, D.E.; Lekovich, J.P.; Rosenwaks, Z. 2015: Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles Journal of Assisted Reproduction and Genetics 32(4): 527-532
Kably Ambe, A.; Barrón Vallejo, J.; Fernández Castro, M.; Karchmer Krivitzky, S. 2000: Changes in preovulatory molecular relationship between estradiol and progesterone in patients undergoing controlled ovarian hyperstimulation. Can they be used for the evaluation of ovarian reserve? Ginecologia y Obstetricia de Mexico 68: 363-367
Dickey, R.P.; Taylor, S.N.; Lu, P.Y.; Sartor, B.M.; Rye, P.H.; Pyrzak, R. 2003: High order multiple pregnancy resulting from controlled ovarian hyperstimulation and intrauterine insemination can be predicted by the number of preovulatory follicles, estradiol levels, and age Fertility and Sterility 80(Suppl 3): S217
Papageorgiou, T.; Guibert, J.; Goffinet, Fçois.; Patrat, C.; Fulla, Y.; Janssens, Y.; Zorn, J-René. 2002: Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome Human Reproduction 17(11): 2846-2850
Fanchin, R.; de Ziegler, D.; Taieb, J.; Olivennes, F.; Castracane, V.D.; Frydman, R. 2000: Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation Fertility and Sterility 73(2): 275-279
Maldonado, L.; Busato, W.; Rossi, L.; Bonetti, T.; Iaconelli Jr., A.; Borges Jr., E. 2005: Estradiol Levels on day 3 and 5 as an Early Predictor of Ovarian Hyperstimulation Syndrome Fertility and Sterility 84: S273-S274
Franco, J.G.Jr.; Vagnini, L.D.; Inouye, M.T.N.; Baruffi, R.L.R.; Oliveira, J.B.A. 1992: Prevention of ovarian hyperstimulation syndrome by measurement of plasma estradiol levels Human Reproduction 7(Suppl 2): 155
Younis, J.S.; Ben-Shlomo, I.; Ben-Ami, M. 2010: Premature luteinization defined by an increased progesterone/estradiol ratio on day of human chorionic gonadotropin administration is a manifestation of diminished ovarian responsiveness to controlled ovarian hyperstimulation Fertility and Sterility 93(6): E29; Author Reply E30
Mitwally, M.F.M.; Bhakoo, H.S.; Crickard, K.; Sullivan, M.W.; Batt, R.E.; Yeh, J. 2006: Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer Fertility and Sterility 86(3): 588-596
Erzincan, S.G.; Esmer, A.C.; Baysal, B. 2014: Does the estradiol level on the day of human chorionic gonadotropin administration predict the clinical outcome of controlled ovarian hyperstimulation? Clinical and Experimental Obstetrics and Gynecology 41(6): 709-712